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THE discovery of the milk factor or mammary tumour agent (Bittner, 1936)
andthe demonstration that three factors, namely, the genetic factor, thehormonal
factor, and the milk factor, are essential for the development of spontaneous
breast cancer in certain inbred strains of mice (Bittner, 1939), was followed by
investigations of the part played by the agent in the induction of breast cancer
by oestrogenic hormone. Lacassagne (1939a), Lacassagne and Danysz (1939),
Twombly (1939, 1940), and later Bittner (1940, 1941), Gardner (1941a), Shimnkin
and Andervont (1941, 1942), Dmochowski and Gye (19.44), found that foster-
nursing of low-breast-cancer strain mice by high-breast-cancer strain females
increases the incidence of breast cancer in the low-breast-cancer strain mice
treated with oestrogenic hormones. Tlhus male mice do not develop breast cancer,
even if they are susceptible and have the mammary tumour agent, unless the
hormonal or oestrogenic factor is supplied, and only few or no breast tumours
are induced in low-breast-cancer strain mice, i.e. in the absence of milk factor,
following treatment with oestrogenic hormones. It is probable that a quantitative
deficiency of any one factor can be overcome by a relative quantitative increase
in the other two factors (Shimkin, 1945).
The accelerating influence of carcinogenic hydrocarbons on the appearance
of breast cancer in mice of unmknow-n genetic constitution was first observed by
Maisin and Coolen (1936) and Perry and Ginzton (1937), while Dobrovolskaia-
Zavadskala and Adamova (1938, 1939), were unable to observe a similar effect
on inbred mice employed by them. Experiments carried out by Mider and
Morton (1939), Bonser and Orr (1939), Strong and Smith (1939), Bonser (1940),
Strong and Williams (1941), Engelbreth-Holm (1941), Engelbreth-Holm and
Lefevre (1941), Orr (1943), Kirschbaum, Lawrason, Kaplan and Bittner (1944),
Kirschbaum, Williams and Bittner (1946), Shimkin and Bryan (1943), Strong
(1945), Orr (1946), demonstrated that carcinogenic hydrocarbons induce the
appearance of breast cancer in females of low-cancer strains or accelerate the
development of breast tumours in female mice of high-cancer strains. In these
experiments it was also shown that oestrogenic influence is important in the
induction of breast cancer by carcinogenic hydrocarbons, since mice developing
these tumours in the absence oftreatment with oestrogens were females, with one
exception, a CBA male (Orr, 1943). The strains employed, the various routes by
which the carcinogenic hydrocarbons were given and the results obtained by
different workers are presented in Table I.INDUCTION OF BREAST CANCER IN MICE
In connection with these observations, experiments were undertaken in order
to ascertain the possibility of induction of breast cancer in mice of a high- and a
low-cancer strain by treatment with oestrogenic hormones, methytcholanthrene,
and combined application of oestrogens and methylcholanthrene.
MATERIAL AND METHODS.
C57 black low-breast-cancer strain females and males, and C3H11 high-breast-
cancer strain males were used. The male mice of both strains, when 60-70 days
old, were divided into three groups: mice ofthe first group received oestrone and
methylcholanthrene, mice of the second group methylcholanthrene alone, and
mice of the third group oestrone alone. C57 strain females, when 6 weeks old,
were divided into two groups: mice of the first group were forcibly bred, mice
of the second group were maintained as virgins; both groups were treated with
methylcholanthrene alone.
Oestrone was applied as a 0.02 per cent solution ofketo-hydroxy-oestrone in
alcohol, by painting the mice twice weekly for a period of 12 months. Methyl-
cholanthrene was administered according to the method described by Orr (1946).
Sixteen drops of 0-5 per cent solution in sweet almond oil were applied, at fort-
nightly intervals, to the skin of mice, four on each side of the dorsal and ventral
surfaces of each animal.
The C57 females of both groups received fortnightly applications of methyl-
cholanthrene from the age of 6 weeks till death or the appearance of a tumour.
In male mice the mammary gland is in a rudimentary state and they do
not have nipples (Lacassagne, 1936). Administration of oestrogenic hormones
leads to the progressive development of the mammary glands described in detail
by Turner and Gomez (1934), Burrows (1935, 1936), Gardner (1935, 1939, 1941b),
Lacassagne (1939b), Loeb (1940), Loeb and Suntzeff (1941). This process does not
progress beyond hyperplasia of ducts and acini in male mice of strains in which
breast cancer does not appear spontaneously. The nipples cannot be found,
however, in male mice even after intensive treatment with oestrogens (Orr,
1943). Because of these observations and the findings that breast cancer can be
induced by methylcholanthrene in males treated simultaneously with oestrogens
(Orr, 1943), the C57 and C3H strain males were painted for 3 months with oestrone
before the treatment with methylcholanthrene. After 3 months of painting with
oestrone both the 057 and C3H males received their first application of methyl-
cholanthrene which was then continued at fortnightly intervals until death or
appearance of a tumour, except in the group ofC3H males painted with oestrone
which received only 14 applications of methylcholanthrene. All animals were
examined once a week for the appearance of tumours.
RESULTS.
The results are shown in Tables II and III.
As can be seen from Table II, one breast tumour developed in C57 low-breast-
cancer strain males treated with oestrone and methylcholanthrene. No tumours
were induced in C57 males after treatment with oestrone or methylcholanthrene
alone. Breast tumours developed in breeding and virgin C57 female mice which
were treated with methylcholanthrene. The number of mice is too small for any
conclusions to be drawn about the difference in the tumour incidence between
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the breeding and the virgin females. Tumours were also induced in C3H high-
breast-cancer strain males which were painted with oestrone alone, and with
oestrone and methylcholanthrene combined (Table III). The percentage tumour
incidence in males treated with oestrone alone does not significantly differ from
that in males treated with oestrone and methylcholanthrene (D/S.E. = 1.4).
There is no significant difference between the average tumour ages of C3H males
of the two groups (D/S.E. = 08).
There was a considerable mortality among the experimentalmice. The changes
observed included loss of weight, retardation of body growth, atrophy of spleen
and thymus, retention of urine, hydronephrosis. Two 057 males and one C57
female, which were treated with methylcholanthrene, developed general enlarge-
ment of lymphoid tissue, and in the C57 male which developed breast cancer a
lymphosarcoma was found in the abdominal cavity. One C57 virgin female
developed a spindle-celled sarcoma in the subcutaneous tissue.
Skin tumours were foundin 10 out of 18 C57 males treated with methylcholan-
threne alone and in 10 out of 35 C57 males treated with oestrone and methyl-
cholanthrene. In C57 breeding females, 8 out of 12, and in C57 virgin mice, 3
out of 11, developed skin tumours. Skin tumours were also found in 4 out of
23 C3H males painted with oestrone and methylcholanthrene and in 8 out of 22
03H males. treated with methylcholanthrene. In 4 C3H males which showed
skin tumours mammary tumours were also present. The skin tumours, however,
were not examined histologically and so their malignancy has not been estab-
lished.
All breast tumours were examined microscopically. The tumours induced by
oestrone in C3H males resembled in every detail the mammary tumours which
develop spontaneously in C3H female mice. Squamous metaplasia was observed
in two tumours induced in 03H males by oestrone and.methylcholanthrene.
The breast tumours induced in C57 mice, both male and female mice, showed a
much greater degree of squamous metaplasia than the breast tumours induced
in C3H male mice. In some ofthe inducedtumours, as in the case ofspontaneous
tumours, variations in structure between different parts of the same tumour
were found. Sometimes the tumour cells were packed in solid sheets while else-
where they occurred singly or-in smallgroups surrounded by anabundant stroma;
in some parts acinar structure could be clearly seen while in other parts it was
lost entirely; in places elongated cords of spindle-shaped tumour cells were
found. Metastases were observed only once, in one df the axillary glands of the
tumour-bearing C57 male.
DISCUSSION.
Mammary tumours were induced in 03H high-breast-cancer strain males
after cutaneous administration of methylcholanthrene combined with the appli-
cation of an oestrogenic hormone. Treatment with the carcinogen alone failed
to induce mammary cancer in C3H high- and 057 low-breast-cancer strain males.
Combined administration of methylcholanthrene and oestrogen induced breast
cancer in a C57 low-breast-cancer strain male. Thus the observations recorded
by previous workers in this field were confirmed and the influence of hormonal
factors on the development ofcarcinogen-induced breast cancer in mice shown.
Mammary tumours were also induced in C57 low-breast-cancer strain
females, both breeding and non-breeding. This observation again confirmed the
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results of other investigators. It is, therefore, possible to induce breast cancer
in mice, both males and females, which lack the mammary tumour agent.
In the present experiments breast cancer was induced in mice of a sub-line
ofC57 blacklow-breast-cancer strainwhich has a lowsusceptibility to spontaneous
breast cancer. Breast tumours developed in C57 black strain females, both breed-
ing and non-breeding, after treatment with methylcholanthrene, and a C57 black
strain male after combined treatment with oestrone and methylcholanthrene.
It is not known whether the failure of Kirschbaum, Williams and Bittner (1946)
to induce breast cancer in breeding C57 black strain females with methylcholan-
threne was due to the different method of application of methylcholanthrene or
to differences in susceptibility ofthe two sub-lines ofthe C57 strain. No tumours
were observed in either C3H or C57 black strain males treated with methylchol-
anthrene alone. This supports the findings of other workers that hormonal
factorsplay a part in the development oftumoursinducedby methylcholanthrene.
Orr (1943), however, reported the induction of breast cancer in one out of 16
CBA low-breast-cancer strain males after intranasal administration of methyl-
cholanthrene in the absence of treatment with oestrogen. He also obtained
breast cancer in virgin mice of two low-breast-cancer strains (IF and CBA)
after treatment with methylcholanthrene. In the present experiments tumours
developed in two non-breeding C57 females treated with methylcholanthrene.
Mider and Morton (1939) failed to induce breast cancer in non-breeding dba
high-breast-cancer strain mice, while Strong and Smith (1939), Strong and
Williams (1941) and Strong (1945) in their successfulexperiments on the induction
of breast cancer in JK, NH and NHO low-breast-cancer strain mice employed
breeding females only.
The present experiments confirm the findings of other workers that breast
tumours can be induped in male mice of susceptible strains after treatment with
oestrogenic hormones (Shimkin and Andervont, 1941, 1942; Bittner, 1941;
Dmochowski and Gye, 1944; Bonser, 1944a, 1944b). The present findings also
confirm the observation that mammary tumours develop in mice of resistant
strains following treatment with methylcholanthrene. The C57 low-breast-
cancer strain mice of the sub-line used, when foster-nursed soon after their birth
by RIII high-breast-cancer strain females, develop an incidence of 11 per cent
of breast tumours, but fail to develop breast cancer when given the tumour
agent at the age of 4-6 weeks, even after large quantities of the agent and in
spite of increased hormonal stimulation by repeated pregnancies (Dmochowski,
1948). Thus mature mice of this strain though resistant to the mammary
tumour agent are susceptible to a different agent, i.e. methylcholanthrene.
The treatment with oestrogenic hormones failed to induce breast cancer in C57
low-cancer strain males. This again confirms the previous findings (Twombly,
1939, 1940; Bittner, 1940, 1941; Shimkin and Andervont, 1941, 1942; Dmo-
chowski and Gye, 1944) that an increased oestrogenic stimulation overcomes the
threshold of low- or non-susceptibility and results in the development of breast
tumours only in the presence of the mammary tumour agent.
Treatment with methylcholanthrene induced in C57 black low-cancer strain
females, breast tumours which, although similar in their structure to spontaneous
breast cancer of high- and of low-breast-cancer strain mice, show an increased
incidence of squamous metaplasia. The tendency to squamous metaplasia was
found in 2 out of 12 tumours induced in C3H males by the combined treatment
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with oestrogen and methylcholanthrene and none was found among the 8 tumours
in G3H males following treatment with oestrogen. These changes were much
less pronounced than those found in methylcholanthrene-induced breast tumours
of C57 black strain mice or IF strain mice (Orr, 1946). Kirschbaum, Williams
and Bittner (1946) came to the conclusion that the histogenesis of methylcholan-
threne-induced tumours is different from that of spontaneous tumours.
The development of breast cancer in mice of high- as well as of low-breast-
cancer strains following treatment with carcinogenic hydrocarbons made the
explanation of the origin of such tumours as a result of the oestrogen-like action
of methylcholanthrene inadequate and made it necessary to determine whether
any part was played by the mammary tumour agent in the development of
methylcholanthrene-induced tumours, especially in low-breast-cancer strains.
Experiments, which will be described in a later paper, were therefore under-
taken in order to ascertain whether methylcholanthrene can induce the
production of the mammary tumour agent-either by activating a dormant agent
or by newly forming it.
SUMMARY.
Breast tumours developed in 03H high- and 057 black low-breast-cancer
strain male mice following cutaneous administration of a 0 5 per cent solution of
methylcholanthrene in almond oil, combined with painting with a 0-02 per cent
solution of oestrone in alcohol. No tumours developed in males of these two
strains following treatment with methylcholanthrene alone, while the application
ofoestrone gave breast tumours in C3H strain males, but not in C57 black strain
males.
Mammary cancer developed in both breeding and non-breeding C57 black
low-breast-cancer strain females after similar treatment with methylcholanthrene.
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IN a previous communication (Berenblum and Shubik, 1947) it was shown
that the non-carcinogenic agent, croton oil, could elicit tumours in the mouse's
skin following an interval of as long as 20 weeks after a single application of the
carcinogen, 9:10-dimethyl-1:2-benzanthracene, and that the number of tumours
produced was the same as that obtained when the interval was only 3 days.
The evidence was considered as strong support in favour of the hypothesis that
the carcinogen, as initiator, converts a small number of cells to " latent tumour
cells," and that the latter persist unchanged until promoted by a further stimulus
into morphological tumours.
The present investigation has been undertaken to determine the limits
within which such a hypothesis remains tenable, by studying the effect of a
time interval much longer than 20 weeks between the single application of the
carcinogen and the commencement of croton oil treatment.
METHODS.
White, female mice ofthe Swiss strain, originating from the Medical Research
Council and bred in this laboratory, were used. They were maintained through-
out on an adequate diet, with water ad lib., as in the previous investigations
by the authors.